Among the newly identified biomarkers of AKI, urine neutrophil gelatinase-associated lipocalin (NGAL) and [TIMP-2]·[IGFBP7] have provided promising results [14,19,45]. This evidence concerns the gene TIMP2 and acute kidney injury.